UBS Oncology Impact Fund L.P. - Insider Trading & Ownership

Entity
Company
Location
450 Kendall Street, Cambridge, MA
Summary
The estimated value of insider holdings of UBS Oncology Impact Fund L.P. is at least $95.3M dollars as of June 5, 2023. UBS Oncology Impact Fund L.P. is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $95.3M.
All Insider Reports
All Insider Reports

Ownership of UBS Oncology Impact Fund L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CGEM Cullinan Therapeutics, Inc. 10%+ Owner $95.3M Sep 16, 2021
TCRR TCR2 THERAPEUTICS INC. 10%+ Owner Jun 1, 2023

Insider Transactions Reported by UBS Oncology Impact Fund L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.